Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback